<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04198220</url>
  </required_header>
  <id_info>
    <org_study_id>HS064</org_study_id>
    <nct_id>NCT04198220</nct_id>
  </id_info>
  <brief_title>BIO|STREAM.ICM Obesity</brief_title>
  <official_title>BIO|STREAM.ICM Obesity, Submodule of the BIO|STREAM.ICM Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the submodule study is to assess whether a high BMI may influence the sensing
      performance and the sECG quality of the BIOMONITOR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This submodule of the BIO|STREAM.ICM registry specifically investigates the performance of
      the BIOMONITOR in a subset of obese patients with a BMI &gt;30 kg/m2 in order to exclude any
      concerns regarding impaired ICM sensing performance. These concerns are founded in the
      increased distance between heart and device electrodes due to fat layers that may attenuate
      signal detection and therefore sensing performances of the ICM.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 31, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>R-wave amplitude</measure>
    <time_frame>3 month</time_frame>
    <description>R-wave amplitude at 3-month Home Monitoring observation in patients with a BMI &gt; 30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of 'noise burden'</measure>
    <time_frame>3 month</time_frame>
    <description>Measurement of amount of 'noise burden' during the study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>P-wave visibility</measure>
    <time_frame>1 month and 3 month</time_frame>
    <description>Measurement of the P-wave visibility at 1- and 3-month Home Monitoring observation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of arrhythmias</measure>
    <time_frame>3 month</time_frame>
    <description>Assessment of the incidence of arrhythmias in obese patients implanted with an ICM</description>
  </other_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Tachycardia Atrial</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Syncope</condition>
  <condition>Bradycardia</condition>
  <condition>Cryptogenic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The patient population consists of obese patients (BMI &gt; 30 kg/m2) with an implantable
        cardiac monitor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is already enrolled in the BIO|STREAM.ICM registry

          -  Patient BMI &gt; 30

        Exclusion Criteria:

          -  Patient clinically indicated for or already implanted with another cardiac active
             device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Bisignani, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Civile Ferrari</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabrina Hoche, Dr.</last_name>
    <phone>+49 (0) 30 68905-1337</phone>
    <email>obesity-biomonitor@biotronik.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Buttgereit, Dr.</last_name>
    <phone>+49 30 68905 1267</phone>
    <email>biomonitor-registry@biotronik.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale Civile Ferrari</name>
      <address>
        <city>Castrovillari</city>
        <zip>87012</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>BIOMONITOR</keyword>
  <keyword>BIOMONITOR III</keyword>
  <keyword>Syncope</keyword>
  <keyword>Cryptogenic stroke</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

